DCDC Health Services raises Rs 150 cr from ABC Impact

IMT News Desk
IMT News Desk
· 2 min read

The fresh funds will facilitate the rollout of over 150 new clinics across the country in the coming months

Dialysis centres operator DCDC Health Services has raised Rs 150 crore from Singapore-based ABC Impact, the Asia-focussed impact investor backed by Temasek.

The company, which operates dialysis centres under the DCDC Kidney Care brand, said the fresh funds will facilitate the rollout of over 150 new clinics across the country in the coming months.

Founded in 2009, DCDC operates more than 200 centres across India.

“This investment from ABC Impact will help enhance our efforts to transform kidney care in India. With this investment, we plan to expand our network of company-owned centres, ensuring last-mile connectivity and making high-quality dialysis care accessible closer to patients’ homes,” DCDC Founder and CEO, Aseem Garg said.

He further said the company plans to extend its solutions to countries beyond India.

ABC Impact Chief Impact Officer Sugandhi Matta said, “With the growing burden of kidney disease in India, increasing access to quality dialysis is both a healthcare and economic necessity. DCDC’s proven model of expanding affordable dialysis services aligns with our commitment to improving healthcare outcomes while ensuring long-term sustainability.”

DCDC has investors, including IFU, a Danish government-owned investment fund and ADB (Asian Development Bank), among its existing shareholders.

Read Next

Granules India posts Rs 13,879 million revenue from operations at Q3FY26
Finance
January 28, 2026

Granules India posts Rs 13,879 million revenue from operations at Q3FY26

Net debt stood at Rs 10,151 million and net debt to EBITDA at 0.91x Granules India has announced its financial results for the quarter ended December 31, 2025. Revenue from Operations of Q3FY26 stood at Rs 13,879 million, a growth of 22 per cent YoY driven by Finished Dosages (FD) segment in North America and […]
Article by: IMT News Desk
OneSource Pharma’s revenue down at Rs 2,903 million in Q3FY26
Finance
January 28, 2026

OneSource Pharma’s revenue down at Rs 2,903 million in Q3FY26

Impacted by delayed semaglutide approvals in Canada OneSource has posted the Q3FY26 results. Revenues were at Rs 2,903 million, down 26 per cent YoY, impacted by delayed semaglutide approvals in Canada. The EBITDA was at Rs 173 million, down 88 per cent YoY, due to lower revenue in the quarter and largely fixed cost base. […]
Article by: IMT News Desk
Syngene International’s Q3 revenue from operations dip 3% year-on-year to Rs 917 Cr
Finance
January 27, 2026

Syngene International’s Q3 revenue from operations dip 3% year-on-year to Rs 917 Cr

Reported revenue dips to Rs 932 crore in the same quarter Syngene International announced financial results for the third quarter of FY26. Peter Bains, Managing Director and CEO, Syngene International, said, “Our Q3 performance reflects the ongoing impact related to a single product from one of our large-molecule biologics clients. Outside of this factor, the […]
Article by: IMT News Desk
Sigachi Industries aims to increase revenue potential by Rs 250 cr commencing from Q427
Finance
January 27, 2026

Sigachi Industries aims to increase revenue potential by Rs 250 cr commencing from Q427

Sigachi’s entry into CF APIs positions the company in a structurally strong and innovation-led therapeutic segment with long-term demand visibility Sigachi Industries announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) combination comprising Vanzacaftor, Tezacaftor, and Deutivacaftor. The development marks […]
Article by: IMT News Desk